A controlled field trial of an aluminum phosphate-adsorbed cholera vaccine in Calcutta. 1980

S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar

A controlled field trial to determine the efficacy of a single dose of an aluminium phosphate-adsorbed cholera vaccine was conducted in Calcutta during 1975-77. An aluminium phosphate-adsorbed tetanus toxoid was used as the placebo. Follow-up of the immunized volunteers for a period of two years showed that the adsorbed cholera vaccine provided 100% protection to children under five years of age for 6 months, 88.9% for 12 months, and 91.7% for 18 months (P<0.05). The overall protection for all age groups was 58.5% for 18 months. There were no serious side effects following the anti-cholera inoculations.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002771 Cholera An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated. Vibrio cholerae Infection,Choleras,Infection, Vibrio cholerae,Infections, Vibrio cholerae,Vibrio cholerae Infections
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
January 1967, Bulletin of the World Health Organization,
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
November 1952, Medical bulletin (Ann Arbor, Mich.),
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
March 1982, Lancet (London, England),
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
January 1978, Bulletin of the World Health Organization,
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
July 1964, Bulletin of the Calcutta School of Tropical Medicine,
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
April 1997, Lancet (London, England),
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
January 1973, Archiv fur die gesamte Virusforschung,
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
January 1978, Bulletin of the World Health Organization,
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
July 1965, The Indian journal of medical research,
S C Pal, and B C Deb, and P G Sen Gupta, and S P De, and B K Sircar, and D Sen, and S N Sikdar
January 1950, Rendiconti - Istituto superiore di sanita,
Copied contents to your clipboard!